|

Hormone Therapy Clinical Trials

5 actively recruiting trials across 3 locations

Also known as: Chemotherapy-Hormones/Steroids, Endocrine Therapy, Hormonal, Hormonal Systemic Therapy, Hormonal Therapy +2 more

Pipeline

Phase 2: 2Phase 3: 3

Top Sponsors

  • University of Washington1
  • Sven Löffeler1
  • NRG Oncology1
  • Jonsson Comprehensive Cancer Center1
  • David Palma1

Indications

  • Cancer5
  • Stage IVA Prostate Cancer AJCC v82
  • Prostate Adenocarcinoma2
  • Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v81
  • Metastatic Hormone Receptor-Positive Breast Carcinoma1

Other2 trials

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
Phase 3
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
Phase 3

Phoenix, Arizona1 trial

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Cancer Center at Saint Joseph's

Phase 3

Los Angeles, California1 trial

Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

UCLA / Jonsson Comprehensive Cancer Center

Phase 2

Seattle, Washington1 trial

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

Fred Hutch/University of Washington Cancer Consortium

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.